Trino Therapeutics Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Trino Therapeutics Ltd.
Start-Up Previews, October 2013
This Month's Profile Group: Biotechs Share Endocrine Enthusiasm, features profiles of Atterocor, Crinetics Pharmaceuticals, and OctreoPharm Sciences. Plus these Start-Ups Across Health Care: Biom’Up SA, KemPharm, LIM Innovations, Reflectance Medical, and Trino Therapeutics.
Trino Therapeutics Ltd.
Ferns have never been economically important plants, but they have been used by native healers around the globe. Trinity College spin-out Trino Therapeutics Ltd. aims to develop new treatments for inflammatory bowel disease based on compounds with an indane skeleton, a six-member ring joined to a five-member ring, from extracts of a fern of the Onychium species used in traditional Taiwanese medicine.
Out Of The Blocks, June 2013
Brief profiles of these recently formed companies: AntiOp, Deep Brain Innovations, Eco Neurologics Inc., eFFECTOR Therapeutics, ElsaLys Biotech, Synfolia, and Trino Therapeutics.
Recent Financings Of Private Companies, June 2013
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Recent Financings Of Private Companies column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies in the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice